Amount$215M
Post-money valuation$1B
SeriesSeries B
AnnouncedOct 27, 2021
Time since last round266 mo
SectorHealthcare, Immunology, Data, Analytics, Personalized Treatment, Drug Development, Computational Biology, Life Sciences, Therapeutics
Sub-sectorArtificial Intelligence, Machine Learning, Deep Learning
Solid
A solid round with healthy fundamentals.
Round size vs peers
Far above the typical Series B round (7.7× the median) — an outlier.
Syndicate size
Healthy syndicate of 6 investors.
Insider conviction
1 existing investor re-upped — insiders doubling down.
Investor track record
A mix of established and emerging investors.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series B rounds (996)
Round size distribution96th pct
smaller Series B roundslarger
Post-money valuation67th pct
$35Mthis round: $1B$2.6B
